Industry News

• FDA advisory committee recommends approval of Forest Laboratories' Ceftaroline Fosamil   Forest Laboratories announced the FDA Anti-Infective Drugs Advisory Committee voted 21 - 0 in favor of approval of ceftaroline fosamil for the treatment of community acquired bacterial pneumonia (CABP) and voted 18 - 0in favor of approval for complicated skin and skin structure infections.
  Forest Laboratories, Inc. September 07, 2010  
• Bristol-Myers Squibb to acquire ZymoGenetics for $885 million  Bristol-Myers Squibb and ZymoGenetics announced that the companies have signed an agreement for the acquisition of ZymoGenetics by Bristol-Myers Squibb, for $9.75 per share in cash with an aggregate purchase price of approximately $885 million.
  Bristol-Myers Squibb Company September 07, 2010  
• Bruker introduces Icon, a high-performance desktop MRI system   Bruker Corporation announced the introduction of the Icon(TM), a new easy-to-use 1 Tesla desktop MRI scanner that combines simplicity with compact dimensions, in order to bring preclinical magnetic resonance imaging (MRI) within reach for a broader range of molecular imaging laboratories.
  Bruker Corporation September 07, 2010  
• Isotechnika Pharma announces partial conversion of convertible debenture   Isotechnika announced it has received a notice to convert from 3SBio Inc. Under the notice to convert, 3SBio Inc. is converting $1.92 million USD of the $4.5 million USD convertible debenture into Common Shares pursuant to the conversion terms provided by the debenture certificate.
  Isotechnika Pharma Inc. September 07, 2010  
• Unigen announces the launch of Bakutrol, a triple-acting botanical skin care ingredient  Unigen announced the launch of Bakutrol™, a powerful triple-acting botanical skin care ingredient offering anti-microbial, anti-inflammatory and anti-scarring benefits. Unigen is currently discussing licensing agreements with some of the world's premiere manufacturers of quality skin care products.
  Unigen, Inc. September 07, 2010  
• Medtronic gains CE mark for enhanced CoreValve® delivery catheter system  Medtronic announced CE Mark approval and the first global launch of the Medtronic CoreValve® delivery system with AccuTrak™ Stability Layer for transcatheter aortic valve implantation. AccuTrak’s proprietary technology provides physicians enhanced control in the deployment of the CoreValve device.
  Medtronic, Inc. September 07, 2010  
• Scott Garrett resigns as chairman, president and CEO of Beckman Coulter  Beckman Coulter announced that Scott Garrett has resigned as Chairman, President and CEO, effective immediately. Garrett will continue as a full-time non-executive employee of the company through January 15, 2011, focusing his attention on aiding the Board of Directors during this transition.
  Beckman Coulter, Inc. September 07, 2010  
• Merck receives FDA Approval for expanded indications for SAPHRIS® sublingual tablets  Merck announced that the FDA has approved two supplemental new drug applications for SAPHRIS® (asenapine) sublingual tablets to expand the product's indications. SAPHRIS is now indicated for the treatment of schizophrenia in adults.
  Merck & Co., Inc. September 07, 2010  
• Twins needed for HIV vaccine study  The HIV Vaccine Trials Unit – Seattle (HVTU), a program of Fred Hutchinson Cancer Research Center, is looking for pairs of identical or fraternal twins living in Seattle and western Washington to participate in a study of the role of genetics and environment on a research HIV vaccine.
  Fred Hutchinson Cancer Research Center September 07, 2010  
• Mayo Clinic researchers receive $11 million for medical genomics  A Mayo Clinic investigator has been awarded an $11.2 million federal research grant for continuing research of pharmacogenomics, the study of the role of genetics in how a person responds to medication.
  Mayo Clinic September 07, 2010  

(previous 10 articles)    (next 10 articles)